Trademark Overview
On Thursday, November 9, 2023, a trademark application was filed for ATX with the United States Patent and Trademark Office. The USPTO has given the ATX trademark a serial number of 79386489. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, February 6, 2025. This trademark is owned by AlgoTherapeutix. The ATX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical products; veterinary products; chemical preparations for medical use; pharmaceutical preparations; chemico-pharmaceutical products; pharmaceutical substances; medicines; pharmaceutical solutions; diagnostic agents for medical use; chemical products for pharmaceutical use; chemical reagents for medical use; chemical reagents for veterinary use; chemical preparations for medical use; chemical preparations for pharmaceutical use; chemical analysis reagents for medical use; chemical analysis reagents for veterinary use; pharmaceuticals for the treatment of rare diseases; all these products being intended for use in the treatment of complex pain
Scientific and technical research services; technical project studies; scientific laboratory services; carrying out clinical trials for pharmaceutical products; provision of information concerning the results of clinical trials for pharmaceutical products; provision of information in connection with medical and scientific research in the field of pharmaceutical products and clinical trials; biological, clinical and medical research; clinical research; carrying out clinical trials; research in the field of medicines; development of pharmaceutical preparations and medicines; research and development of medicines; research and development of pharmaceutical products; laboratory research services concerning pharmaceutical products; consultancy with respect to pharmaceutical research and development; consulting relating to pharmacology; consultancy in the field of pharmaceutical research; services for conducting early assessments of new pharmaceuticals; all these services being intended to b...
